The data was presented at the Orthopaedic Research Society in Long Beach, Calif. The data shows that several antibodies targeting glucosamindase, a protein, found in the Staphylococcus aereus, can lead to the bug’s demise. Dr. Schwarz and his team discovered four anti-Gmd monoclonal antibodies that disrupt the growth of MRSA bacteria.
Read the Pittsburgh Examiner report on the research.
Read other coverage on studies by orthopedic surgeons:
– University of Toledo Receives NFL Charities Grant for Studying MRSA Spread in Artificial Turf
– Research on Infection-Resistant Orthopedic Implants Receives NSF Funding
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
